| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| June 21st, 2008 | 22 | Yes |
Popular Name: Vildagliptin Vildagliptin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 127254-12-0 , 127254-12-0; 274901-16-5 , 274901-16-5 , [274901-16-5]
(2S)-1-[N-(3-Hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile
(S)-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile
2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
EQUA;Galvus;Jalra;LAF 237;LAF237;NVP-LAF-237;NVP-LAF237;Xiliarx
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.42 | 4.11 | -49.86 | 3 | 5 | 1 | 81 | 304.414 | 3 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 1.75e+00 g/l | DrugBank-approved |
| Purity | 95+% | Matrix Scientific |
| biological_use | Anti-hyperglycemic agent | IBScreen Bioactives |
| Indications | antidiabetic | KeyOrganics Bioactives |
| mechanism | Dipeptidyl peptidase-4 (DPP-4) inhibitor | IBScreen Bioactives |
| Target | DPP-4 | Selleck Chemicals |
| Warnings | IRRITANT | Matrix Scientific |
| Indications | type II diabetes | KeyOrganics Bioactives |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| DPP4-2-E | Dipeptidyl Peptidase IV (cluster #2 Of 3), Eukaryotic | Eukaryotes | 4 | 0.53 | Binding ≤ 10μM |
| DPP4-2-E | Dipeptidyl Peptidase IV (cluster #2 Of 3), Eukaryotic | Eukaryotes | 9 | 0.51 | Binding ≤ 10μM |
| DPP8-1-E | Dipeptidyl Peptidase VIII (cluster #1 Of 2), Eukaryotic | Eukaryotes | 9000 | 0.32 | Binding ≤ 10μM |
| DPP9-1-E | Dipeptidyl Peptidase IX (cluster #1 Of 2), Eukaryotic | Eukaryotes | 680 | 0.39 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| DPP4_HUMAN | P27487 | Dipeptidyl Peptidase IV, Human | 0.58 | 0.59 | Binding ≤ 1μM |
| DPP4_RAT | P14740 | Dipeptidyl Peptidase IV, Rat | 2.3 | 0.55 | Binding ≤ 1μM |
| DPP9_HUMAN | Q86TI2 | Dipeptidyl Peptidase IX, Human | 230 | 0.42 | Binding ≤ 1μM |
| DPP4_RAT | P14740 | Dipeptidyl Peptidase IV, Rat | 2.3 | 0.55 | Binding ≤ 10μM |
| DPP4_HUMAN | P27487 | Dipeptidyl Peptidase IV, Human | 0.58 | 0.59 | Binding ≤ 10μM |
| DPP9_HUMAN | Q86TI2 | Dipeptidyl Peptidase IX, Human | 1200 | 0.38 | Binding ≤ 10μM |
| DPP8_HUMAN | Q6V1X1 | Dipeptidyl Peptidase VIII, Human | 1342 | 0.37 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polyp |